[HTML][HTML] Novel anticoagulants versus vitamin K antagonists for cardioversion of non-valvular atrial fibrillation–a meta-analysis of more than 17000 patients
Non-vitamin K antagonist oral anticoagulants (NOACs) have proven a favorable risk-benefit
profile compared to vitamin K antagonists (VKAs) for preventing stroke and systemic …
profile compared to vitamin K antagonists (VKAs) for preventing stroke and systemic …
Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are at least non-inferior
to Vitamin K Antagonists (VKAs) for stroke prevention on patients with non-valvular atrial …
to Vitamin K Antagonists (VKAs) for stroke prevention on patients with non-valvular atrial …
Efficacy and safety of non-vitamin K antagonist oral anticoagulants after cardioversion for nonvalvular atrial fibrillation
G Renda, M Zimarino, F Ricci, JP Piccini… - The American Journal of …, 2016 - Elsevier
Background Non-vitamin K oral anticoagulants (NOACs) are proven alternatives to vitamin K
antagonists (VKAs) for the prevention of thromboembolism in patients with nonvalvular atrial …
antagonists (VKAs) for the prevention of thromboembolism in patients with nonvalvular atrial …
New oral anticoagulants versus vitamin K antagonists before cardioversion of atrial fibrillation: a meta-analysis of data from 4 randomized trials
G Andò, O Trio, S Carerj - Expert Review of Cardiovascular …, 2015 - Taylor & Francis
Background: Scarce data are available about efficacy and safety of new oral anticoagulants
(NOACs) for cardioversion (CV) of atrial fibrillation (AF). We performed a meta-analysis of …
(NOACs) for cardioversion (CV) of atrial fibrillation (AF). We performed a meta-analysis of …
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: a systematic review and meta-analysis
N Telles-Garcia, K Dahal, C Kocherla, GYH Lip… - International journal of …, 2018 - Elsevier
Background Current guidelines recommend anticoagulation using warfarin with bridging
parenteral anticoagulation or one of the non-vitamin K antagonist oral anticoagulants …
parenteral anticoagulation or one of the non-vitamin K antagonist oral anticoagulants …
Outcomes after cardioversion in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants (NOACs): insights from a meta-analysis
Background There are limited data on outcomes following cardioversion in atrial fibrillation
(AF) patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). A meta …
(AF) patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). A meta …
Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis
ND Brunetti, N Tarantino, L De Gennaro… - Journal of Thrombosis …, 2018 - Springer
Pharmacological or electrical cardioversion allows immediate symptoms improvement in the
setting of paroxysmal or persistent atrial fibrillation (AF), although the periprocedural risk of …
setting of paroxysmal or persistent atrial fibrillation (AF), although the periprocedural risk of …
Non-vitamin K antagonist oral anticoagulants for cardioversion in atrial fibrillation: an updated meta-analysis
G Renda, F Ricci, R De Caterina - The American Journal of Medicine, 2017 - Elsevier
Background Non-vitamin K oral anticoagulants are now proven alternatives to vitamin K
antagonists for stroke prevention in atrial fibrillation. However, there are few data on the …
antagonists for stroke prevention in atrial fibrillation. However, there are few data on the …
Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: a systematic review and meta-analysis of the literature
F Dentali, GL Botto, M Gianni, P Ambrosino… - International journal of …, 2015 - Elsevier
Background DOACs are increasingly used in patients with NVAF. Information on efficacy
and safety of these compounds in patients undergoing electrical or pharmacological …
and safety of these compounds in patients undergoing electrical or pharmacological …
Non vitamin K antagonist oral anticoagulants in atrial fibrillation patients scheduled for electrical cardioversion: a real-life propensity score matched study
A Rago, E Pezzullo… - Journal of blood …, 2021 - Taylor & Francis
Aim The aim of the present study was to assess the safety and effectiveness of non-vitamin K
antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in atrial …
antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in atrial …